Sarah has 15+ years working in healthcare and pharmaceutical industries, and specializes in Value & Evidence. Sarah is experienced in advising, crafting and faciliating cross-functional, multi-stakeholder initiatives, and partners closely with other specialist areas across MEDiSTRAVA and Inizio. She has worked across a wide variety of therapy areas, and with drugs, devices and diagnostics.
Sarah has a PhD in Neuroimmunopharmacology from the University of Birmingham, and has prior experience of working in both the NHS and UK Department of Health.